MOS双等位基因突变导致以植入前胚胎停滞为特征的女性不孕
研究在两家独立的不孕家庭中鉴定出MOS双等位基因突变,患者表现为植入前胚胎停滞(PREMBA)。在HEK293T细胞和小鼠卵母细胞中的功能实验显示,这些突变降低MOS蛋白水平及其下游ERK1/2磷酸化能力,并影响小鼠卵母细胞F-actin骨架,为MOS与女性不孕的因果关系提供证据。
要点
- 在两名PREMBA表型患者中鉴定出MOS双等位基因突变。
- 突变降低MOS蛋白水平及对下游ERK1/2的磷酸化能力。
- 作者认为MOS突变可能作为临床遗传咨询的精确诊断标志物。
核心结论
- 研究鉴定出MOS双等位基因突变,可能引起以植入前胚胎停滞为特征的人类女性不孕,并在HEK293T细胞和小鼠卵母细胞中为MOS与女性不孕的因果关系提供证据。
研究设计与样本
- 采用全外显子组测序、生物信息学过滤分析和遗传学分析,在两家独立家庭中鉴定MOS双等位基因突变。
- 不孕患者表现为早期胚胎停滞,于2018年10月至2020年6月招募。
- 女性原发不孕患者从当地医院生殖中心招募;患者、家庭成员及健康对照的外周血提取基因组DNA。
- 对诊断为PREMBA的患者行全外显子组测序;在HEK293T细胞中用蛋白质印迹、在小鼠卵母细胞中用显微注射和免疫荧光研究突变的功能效应。
主要发现
- 在两名独立患者中鉴定出MOS纯合错义突变c.285C>A(p.(Asn95Lys))以及复合杂合突变c.467delG(p.(Gly156Alafs*18))和c.956G>A(p.(Arg319His))。
- c.285C>A(p.(Asn95Lys))和c.467delG(p.(Gly156Alafs*18))降低MOS蛋白水平。
- 所有突变均降低MOS对下游靶点细胞外信号调节激酶1/2的磷酸化能力。
- 所鉴定突变降低外源性人MOS挽救中期II退出表型的能力。
- 患者来源突变影响小鼠卵母细胞的F-actin细胞骨架。
临床怎么用
- 作者认为MOS突变可能作为临床遗传咨询的精确诊断标志物。
- 作者指出,由于缺乏患者卵母细胞的体内数据,MOS突变导致PREMBA的确切分子机制仍未知,应使用敲除或敲入小鼠进一步研究。
局限性
- 由于缺乏患者卵母细胞的体内数据,MOS突变影响并导致PREMBA的确切分子机制仍未知,应使用敲除或敲入小鼠进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are mutations in MOS (MOS proto-oncogene, serine/threonine kinase) involved in early embryonic arrest in infertile women? SUMMARY ANSWER: We identified mutations in MOS that may cause human female infertility characterized by preimplantation embryonic arrest (PREMBA), and the effects of the mutations in human embryonic kidney 293T (HEK293T cells) and mouse oocytes provided evidence for a causal relation between MOS and female infertility. WHAT IS KNOWN ALREADY: MOS, an activator of mitogen-activated protein kinase, mediates germinal vesicle breakdown and metaphase II arrest. Female MOS knockout mice are viable but sterile. Thus, MOS seems to be an important part of the mammalian cell cycle mechanism that regulates female meiosis. STUDY DESIGN, SIZE, DURATION: Whole-exome sequencing, bioinformatics filtering analysis and genetic analysis were performed to identify two different biallelic mutations in MOS in two independent families. The infertile patients presenting with early embryonic arrest were recruited from October 2018 to June 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: The female patients diagnosed with primary infertility were recruited from the reproduction centres of local hospitals. Genomic DNA from the affected individuals, their family members and healthy controls was extracted from peripheral blood. We performed whole-exome sequencing in patients diagnosed with PREMBA. Functional effects of the mutations were investigated in HEK293T cells by western blotting and in mouse oocytes by microinjection and immunofluorescence. MAIN RESULTS AND THE ROLE OF CHANCE: We identified the homozygous missense mutation c.285C>A (p.(Asn95Lys)) and the compound heterozygous mutations c.467delG (p.(Gly156Alafs*18)) and c.956G>A (p.(Arg319His)) in MOS in two independent patients. The mutations c.285C>A (p.(Asn95Lys)) and c.467delG (p.(Gly156Alafs*18)) reduced the protein level of MOS, and all mutations reduced the ability of MOS to phosphorylate its downstream target, extracellular signal-regulated kinase1/2. In addition, the identified mutations reduced the capacity of exogenous human MOS to rescue the metaphase II exit phenotype, and the F-actin cytoskeleton of mouse oocytes was affected by the patient-derived mutations. LIMITATIONS, REASONS FOR CAUTION: Owing to the lack of in vivo data from patient oocytes, the exact molecular mechanism affected by MOS mutations and leading to PREMBA is still unknown and should be further investigated using knock-out or knock-in mice. WIDER IMPLICATIONS OF THE FINDINGS: We identified recessive mutations in MOS in two independent patients with the PREMBA phenotype. Our findings reveal the important role of MOS during human oocyte meiosis and embryonic development and suggest that mutations in MOS may be precise diagnostic markers for clinical genetic counselling. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (81725006, 81822019, 81771581, 81971450, 81971382,82001538 and 82071642), the project supported by the Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), the Project of the Shanghai Municipal Science and Technology Commission (19JC1411001), the Natural Science Foundation of Shanghai (19ZR1444500 and 21ZR1404800), the Shuguang Program of the Shanghai Education Development Foundation and the Shanghai Municipal Education Commission (18SG03), the Foundation of the Shanghai Health and Family Planning Commission (20154Y0162), the Capacity Building Planning Program for Shanghai Women and Children's Health Service and the collaborative innovation centre project construction for Shanghai Women and Children's Health. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Zeng Y, Shi J, Xu S, et al. Bi-allelic mutations in MOS cause female infertility characterized by preimplantation embryonic arrest. Hum Reprod. 2022. PMID: 34997960. doi:10.1093/humrep/deab281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。